Huntington National Bank Has $17.94 Million Holdings in Colgate-Palmolive (NYSE:CL)

Huntington National Bank lifted its stake in Colgate-Palmolive (NYSE:CL) by 10.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 172,829 shares of the company’s stock after acquiring an additional 16,121 shares during the period. Huntington National Bank’s holdings in Colgate-Palmolive were worth $17,941,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Kingsview Wealth Management LLC raised its holdings in Colgate-Palmolive by 10.0% in the 1st quarter. Kingsview Wealth Management LLC now owns 14,088 shares of the company’s stock valued at $1,269,000 after acquiring an additional 1,285 shares in the last quarter. Dorsey & Whitney Trust CO LLC raised its stake in shares of Colgate-Palmolive by 32.8% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 3,635 shares of the company’s stock valued at $327,000 after purchasing an additional 898 shares in the last quarter. 1ST Source Bank bought a new position in Colgate-Palmolive in the first quarter worth $201,000. Motco boosted its stake in Colgate-Palmolive by 16.5% during the first quarter. Motco now owns 6,016 shares of the company’s stock worth $542,000 after buying an additional 853 shares in the last quarter. Finally, Banco Santander S.A. increased its holdings in Colgate-Palmolive by 77.5% in the 1st quarter. Banco Santander S.A. now owns 19,319 shares of the company’s stock valued at $1,740,000 after buying an additional 8,436 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of analyst reports. Evercore ISI raised their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $91.44 on Friday. The stock has a market cap of $74.71 billion, a price-to-earnings ratio of 26.20, a P/E/G ratio of 3.27 and a beta of 0.42. Colgate-Palmolive has a 12-month low of $75.17 and a 12-month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business’s 50-day simple moving average is $99.94 and its 200 day simple moving average is $98.48.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.